BamSEC and AlphaSense Join Forces
Learn More

Aptalis Holdings Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.28
from S-1 4 pages Amendment No. 1 to Share Purchase Agreement
12/34/56
EX-10.27
from S-1 72 pages Share Purchase Agreement by and Among Axcan Holdings Inc., Axcan Pharma Holding B.V. and Eurand N.V. Dated as of November 30, 2010
12/34/56
EX-10.21
from S-1 159 pages December 28, 2011 Strakan International S.À R.L. Prostrakan Inc. (For the Purposes of Sections 5.1 and 11.1.2) – And – Aptalis Pharma US, Inc. Commercialization and License Agreement
12/34/56
EX-10.20
from S-1 161 pages Agreement and Plan of Merger by and Among Axcan Holdings Inc., Axcan Lone Star Inc., Mpex Pharmaceuticals, Inc. and the Securityholders’ Representative Committee April 11, 2011
12/34/56
EX-10.19
from S-1 7 pages Second Amendment to Lease
12/34/56
EX-10.18
from S-1 23 pages First Amendment to Lease
12/34/56
EX-10.17
from S-1 104 pages -II- Agreement of Lease
12/34/56
EX-10.16
from S-1 7 pages Eleventh Amendment to Lease
12/34/56
EX-10.15
from S-1 17 pages Standard Lease Form
12/34/56
EX-10.14
from S-1 10 pages Amended and Restated Aptalis Holdings Inc. Employee Long Term Incentive Plan
12/34/56
EX-10.13
from S-1 5 pages Axcan Holdings Inc. Management Equity Incentive Plan 2008 Appendix: French Sub-Plan
12/34/56
EX-10.12
from S-1 22 pages Amended and Restated Aptalis Holdings Inc. Management Equity Incentive Plan
12/34/56
EX-10.10
from S-1 22 pages Guaranty Dated as of October 4, 2013 Among Aptalis Midholdings Inc., Aptalis Pharma Inc., Aptalis Pharma Canada Inc., Certain Other Subsidiaries of Aptalis Pharma Inc. Identified Herein and Bank of America, N.A., as Administrative Agent
12/34/56
EX-10.8
from S-1 20 pages License Agreement Between Nordmark Arzneimittel Gmbh & Co. Kg Pinnauallee 4 25436 Uetersen Germany — Hereinafter Referred to as Licensor — And Eurand S.P.A. via Martin Luther King, 13 20060 Pessano Con Bornago - Milano Italy — Hereinafter Referred to as Licensee — (Both Parties Referred to as the Parties, the License Agreement Referred to as the Agreement) Relating to Pancreatin (Api) Documentation Preamble
12/34/56
EX-10.7
from S-1 19 pages Supply Contract
12/34/56
EX-10.6
from S-1 3 pages Amendment No. 1 to the Supply Agreement Between Aptalis Pharma Canada, Inc. and Infar
12/34/56
EX-10.5
from S-1 20 pages Supply Agreement Between Infar and Axcan Pharma Inc
12/34/56
EX-10.4
from S-1 3 pages Amendment to the Supply Agreement Between Aptalis Pharma Canada, Inc. (Formerly Axcan Pharma, Inc.) and Paddock Laboratories, LLC
12/34/56
EX-10.3
from S-1 50 pages Supply Agreement Between Paddock Laboratories, Inc. and Axcan Pharma Inc. Dated: May 7, 2004
12/34/56
EX-10.2
from S-1 8 pages Amendment No. 1 to the Finished Product Supply Agreement
12/34/56